The association of hyperandrogenism and insulin resistance in polycystic ovary syndrome (PCOS) is well assessed (1) and it is known that serum levels of insulin and androgens are increased and reciprocally related (2) , but the pathophysiology of this association has not yet been clarified. It has been suggested that both hyperinsulinemia and hyperandrogenemia are due to a decreased insulin sensitivity at peripheral levels (2, 3) . Moreover, there is evidence that insulin suppression is able to reduce serum testosterone in PCOS (4) , although it is uncertain whether insulin administration or increased serum insulin levels are able to enhance androgen production (5) (6) (7) (8) .
On the other hand, some reports indicate that hyperandrogenism is the primary biochemical abnorm¬ ality in PCOS, whereas hyperinsulinemia is a conse¬ quence of it. This view is based on the experimental observation that circulating insulin levels may be increased or decreased by androgen (9, 10) 
